Thanks to the success of its COVID-19 vaccine, Pfizer (NYSE: PFE) more than doubled its cash hoard in 2021. Here's how the company's big plan might play out. Pfizer set forth an ambitious goal to use its war chest to add $25 billion of revenue by 2030 through mergers and acquisitions, and it's been actively building its pipeline to reach that goal over the last several months.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting